TONI SEIBERT: Open Payments
NPI 1861860256 · COLUMBUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,373 in 83 payments from 16 companies in 2025. Trend: 2023 $7,425 · 2024 $3,361 · 2025 $9,373
Speaker / faculty: $7,875Food & beverage: $1,273Consulting: $225
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $8,632 |
| Novo Nordisk Inc | 11 | $187 |
| Astellas Pharma US Inc | 4 | $81 |
| Lilly USA, LLC | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Bausch Health US, LLC | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| Lundbeck LLC | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
Products named: VRAYLAR, REXULTI, Ozempic, Veozah, MOUNJARO, Wegovy, CAPLYTA, APLENZIN.
Industry payments across NJ — which companies pay providers there.
